CoChat

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease

Open access
van Duijn, Cornelia M, Havekes, Louis M, Van Broeckhoven, Christine, de Knijff, Peter, Hofman, Albert · 1995 · BMJ
Cited by 80

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Objective : To investigate the hypothesis that differential survival between smokers and nonsmokers leading to a decrease in the frequency of the e4 allele of the apolipoprotein E gene may explain the inverse relation between smoking history and early onset Alzheimer's disease. Design : A population based case-control study. Setting : The four northern provinces of the Netherlands and metropolitan Rotterdam. Subjects : 175 patients with early onset Alzheimer's disease and two independent control groups of 159 and 457 subjects. Main outcome measures : Frequencies of the apolipoprotein e4 allele and relative risk of early onset Alzheimer's disease. Results : The inverse association between smoking history and early onset Alzheimer's disease could not be explained by a decrease in the frequency of the apolipoprotein e4 allele. Among carriers of this allele with a family history of dementia subjects with a history of smoking had a strongly reduced risk of early onset Alzheimer's disease (odds ratio 0.10 (95% confidence interval 0.01 to 0.87)). Conclusions : The results suggest that the inverse relation between smoking history and early onset Alzheimer's disease cannot be explained by an increased mortality in carriers of the apolipoprotein e4 allele who smoke. The association is strongly modified by the presence of the apolipoprotein e4 allele as well as by a family history of dementia. Key messages: Key messages This study shows that the inverse association between smoking history and early onset Alzheimer's disease cannot be explained by a shift in frequency of the apolipoprotein e4 allele The inverse relation was significant only in subjects with a family history of dementia who carry the e4 allele Our study suggests that clinical trials with nicotine or nicotine derivatives have the greatest chance of success in patients with familial Alzheimer's disease who carry the apolipoprotein e4 allele

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.310.6980.627

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 80

Metadata

Authors
van Duijn, C. M., Havekes, L. M., Van Broeckhoven, C., de Knijff, P., & Hofman, A.
Venue
BMJ
Publisher
BMJ
Published
1995-03-11
Volume
310
Issue
6980
Pages
627-631
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2033994360
Cited by
80
References
5
FWCI
4.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. https://app.cochat.ai/papers/10.1136/bmj.310.6980.627
The paper
van Duijn, C. M., Havekes, L. M., Van Broeckhoven, C., de Knijff, P., & Hofman, A. (1995). Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ. https://doi.org/10.1136/bmj.310.6980.627

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.